Gasporox AB (publ)
The answer first
Does Gasporox beat the market?
No, Gasporox has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 2% of Nordic stocks
- Quality2
- Value25
- Trend15
No. 211 of 214 in technology
Expectations in the price
Low expectations
For the share to return about 9% a year from today's price, it is enough that the cash Gasporox keeps shrinks about 5% a year for 10 years.
Max for seven days
Follow Gasporox with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Gasporox
Your first answer is free, no account needed.
Do you own Gasporox, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Gasporox and a few more. Free, no card.
Super Stock+46.4%In short
- Gasporox has fallen 41.5% over the past year, including dividends.
- Overall, Gasporox ranks better than 2% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 76.4%. The price is 84.6% below its peak now.
What do analysts think of Gasporox?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 2% of Nordic stocks.
No. 211 of 214 in technology
Low Weaker accounts than most: low profitability, high debt or uneven results.
No. 212 of 219 in technologyTypical in technology: 52Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.00
- Asset turnoverSales divided by everything the company owns0.78
- Return on equityProfit divided by equity−63.8%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 129 of 217 in technologyTypical in technology: 36Typical in the Nordics: 50
- P/BPrice divided by equity3.1
- P/SPrice divided by sales1.1
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flow8.5
The ranking is built on P/E, P/B and P/S.
Low Headwind in the share price: it has done worse than most over the last year.
No. 169 of 222 in technologyTypical in technology: 38Typical in the Nordics: 50
- 3 months−39.2%
- 6 months−53.2%
- 9 months−44.1%
- 12 months−41.5%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About Gasporox
Gasporox AB (publ) is a company in technology, listed on Nasdaq Stockholm. By market value, Gasporox is number 103 of 144 companies in technology on Nasdaq Stockholm. Gasporox has not paid a dividend in the past twelve months. Of the three measures in the ranking, Gasporox is strongest on value, better than 25% of Nordic stocks. The share trades in SEK. It has around 22 employees.
Gasporox AB (publ) engages in the development and commercialization of tunable diode laser absorption spectroscopy technology in Sweden. The company offers instruments, such as GPX1500 vial, GPX1500 film pharma, and GPX1500 film food; linearch machines; VialArch, BottleArch, AutoMAP pharma and food, and CellSpect sensors; and GPX HMI software. It also provides laboratory services, including alpha studies, multi-parameter analysis, batch check, stability studies, and customer defined studies; and IQ/OQ protocols, remote calibration services, training, and customized accessories for the GPX1500. Gasporox AB (publ) was incorporated in 2005 and is based in Lund, Sweden.


See the full analysis of Gasporox.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card